Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009

Journal of Functional Foods

Volumn 2, Issue 4, 2010, Pages 235-238

  Stohs, Sidney J ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse event reports; Bitter orange; Citrus aurantium; Clinical case reports; P Synephrine

Indexed keywords

CITRUS AURANTIUM;

EID: 78649630706     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2010.10.003     Document Type: Review

References (26)

1. Arbo M.D., Larentis E.R., Linck V.M., Aboy A.L., Pimentel A.L., Henriques A.T., et al. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food and Chemical Toxicology 2008, 46:2770-2775.
2. Bouchard N.C., Howland M.A., Greller H.A., Hoffman R.S., Nelson L.S. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clinic Proceedings 2005, 80:541-545.
3. Carpene C., Galitzky J., Fontana E., Algie C., Lafontan M., Berlan M. Selective activation of beta 3-adrenoreceptors by octopamine: Comparative studies in mammalian fat cells. Naunyn Schmiedebergs Archives Pharmacology 1999, 359:310-321.
4. Dragull K., Breksa A.P., Cain B. Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). Journal of Agricultural and Food Chemistry 2008, 56:8874-8878.
5. Gange C.A., Madias C., Felix-Gretzik E.M., Weintraub A.R., Estes N.A.M. Variant angina associated with bitter orange in a dietary supplement. Mayo Clinic Proceedings 2006, 81:545-548.
6. Gray S., Woolf A.D. Citrus aurantium used for weight loss by an adolescent with anorexia nervosa. Journal of Adolescent Health 2005, 37:415-416.
7. Haaz S., Fontaine K.R., Cutter G., Limdi N., Perumean-Chaney S., Allison D.B. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An update. Obesity Review 2006, 7:79-88.
8. Haller C.A., Benowitz N.L., Jacob P. Hemodynamic effects of ephedra-free weight-loss supplements in humans. American Journal of Medicine 2005, 118:998-1003.
9. Hamilton B.S., Doods H.N. Identification of potential agonists acting at an endogenous atypical β3-adrenoreceptor state that modulate lipolysis in rodent fat cells. European Journal of Pharmacology 2010, 580:55-62.
10. Holmes R.O., Tavee J. Vasospasm and stroke attributable to ephedra-free Xenadrine: Case study. Military Medicine 2008, 173:708-710.
11. Jordan R., Thonoor C.M., Williams C.M. Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. Journal of Pharmacy and Pharmacology 1987, 39:752-754.
12. Ma G., Bavadekar S.A., Schaneberg B.T., Khan I.A., Feller D.R. Effects of synephrine and beta-phenylephrine on human alpha-adrenoceptor subtypes. Planta Medica 2010, 76:981-986.
13. Mattoli L., Cangi F., Maidecchi A., Ghiara C., Stubaro M., Tralda P. A rapid liquid electrospray ionization mass spectroscopy method for evaluation of synephrine in Citrus aurantium L. samples. Journal of Agricultural Food Chemistry. 2005, 53:9860-9866.
14. McGuffin M. Media spins numbers on bitter orange AERs based on erroneous information from FDA. HerbalGram 2006, 69:52-55.
15. Mercolini L., Mandrioli R., Trere T., Bugamelli F., Ferranti A., Raggi M.A. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements. Journal of Separation Science 2010, 32:1-8.
16. Min B., Cios D., Kluger J., White C.M. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter orange extract in healthy subjects. Pharmacotherapy 2005, 25:1719-1724.
17. Nasir J.M., Durning S.J., Ferguson M., Barold H.J.S., Haigney M.C. Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine. Mayo Clinic Proceedings 2004, 79:1059-1062.
18. Nutratech Inc. (2005). Advantra Z®. The next generation weight loss ad fitness ingredient. Applications/dosage guidelines. http://www.nutratechinc.com/advz/advz.php?p=4.
19. Nykamp D.L., Fackih M.N., Compton A.L. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Annals of Pharmacotherapy 2004, 38:812-816.
20. Pellati F., Benvenuti S., Melegari M. High-pressure liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara. Phytochemical Analysis 2004, 15:220-225.
21. Penzak S.R., Jann M.W., Cold J.A., Hon Y.Y., Desai H.D., Gurley B.J. Seville (sour) orange juice: Synephrine content and cardiovascular effects in normotensive adults. Journal of Clinical Pharmacology 2001, 41:1059-1063.
22. Smedema J.P., Muller G.J. Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine. South African Medical Journal 2008, 98:372-373.
23. Stephensen T.A., Sarlay R. Ventricular fibrillation associated with use of synephrine containing dietary supplement. Military Medicine 2009, 174:1313-1319.
24. Stohs S.J., Shara M. A review of the safety and efficacy of Citrus aurantium in weight management. Obesity: Epidemiology, pathophysiology, and prevention 2007, 371-382. CRC Press, Boca Raton (FL). D. Bagchi, H.G. Preuss (Eds.).
25. Sultan S., Spector J., Mitchell R.M. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Mayo Clinic Proceedings 2006, 81:1630-1631.
26. Thomas J.E., Munir J.A., McIntyre P.Z., Ferguson M.A. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement. A case report and review of the literature. Texas Heart Institute Journal 2009, 36:586-590.